Charlotte Manisty
@dr_manisty
Followers
1K
Following
1K
Media
24
Statuses
354
Cardiologist. Specialist in cardio-oncology and cardiac imaging.
Joined September 2019
RT @MycardiumAI: Our EchoConfidence software has just received FDA 510(k) clearance!. Read more from Ed Critchley our Chief Commercial Offi….
0
1
0
RT @MycardiumAI: EchoConfidence has just received FDA 510(k) CLEARANCE, and we're officially changing the game in echocardiography. No mor….
0
5
0
RT @MycardiumAI: Revisiting our podcast with @dr_manisty and @JamesSomauroo on @TheHealthtechPodcast. We discussed how MyCardium AI is adv….
0
1
0
RT @AnaBaracCardio: CV Imaging brings insight & innovation into #CardioOnc Grateful x 2 families that inspire & grow together! @RonBlankste….
0
13
0
@TheBHF @UCL_ICS @ChengshengJ @ninianlang @amibanerjee1 @ICOSociety @BCOSCardioOnc @AnaBaracCardio @DarrylLeong @sdent_cardioonc Using real-world dataset of >100,000 patients, we show 7.7% absolute mortality benefit, compared to <1% risk of CV events (mainly arrhythmia) with no increased risk in those with known CAD. Highlights importance of avoiding therapeutic conservatism and value of #CardioOnc.
0
0
7
Fluoropyrimidine Chemotherapy and the Risk of Death and Cardiovascular Events in Patients With Gastrointestinal Cancer | JACC: CardioOncology
2
15
36
RT @MycardiumAI: 🚀 Podcast out now!. Professor Charlotte Manisty @dr_manisty, Head of Echo, Director, and Co-Founder of MyCardium AI, joins….
0
2
0
RT @MycardiumAI: 🎉 Celebrate the Launch of 1CMR at SCMR 2025 – We’re Here to Make Our Mark!. Join us (@JccmoonMoon, @DrMarkWestwood1 and @….
0
1
0
Thank you @BirkhoelzerS for the invitation. Always a pleasure to raise awareness to cancer patients and survivors of how to improve CV health @BCOSCardioOnc @ICOSociety.
🎙️ Exciting new podcast episode with .@dr_manisty @NHSBartsHealth @ucl . 🔊Tune in to learn how Cardiooncologist ensure hearts stay as strong as the fight we are battling against cancer ❤️.
0
0
4
Thanks @datsunian and @UCLA for inviting me. Multi-modality imaging, multi-disciplinary clinical challenges and transatlantic care - #CardioOnc involves sharing ideas and partnership. @ICOSociety @BCOSCardioOnc.
I am biased but every #cardioonc didactic #bruinhearts lecture is 🔥. but to have the privilege of having @CardiacimagingB #whyCMR guru @dr_manisty weigh in on a challenging case of pacing lead(s) related TV regurgitation & prior chemoradiation by #kevinofee was incredible!.🙏
1
3
14
RT @JACCJournals: Coronary microvascular function is impaired in #obesity, but improves by quantitative #whyCMR perfusion 6 months after #b….
0
15
0
RT @zahra_raisi: 🚨We are looking for a highly motivated, enthusiastic and experienced nurse to join our Cardio-Oncology CNS team at St Bart….
0
8
0
RT @JACCJournals: This #JACCCardioOnc paper evaluates the existing evidence on CV care of #cancer patients before cardiotoxic cancer therap….
0
13
0
RT @DrDCondurache: 📚 Our latest research evaluates the predictive performance of seven established cardiovascular risk scores in cancer sur….
jacc.org
0
8
0
RT @uclnews: Weight loss surgery may reduce the risk of developing heart failure for people living with obesity by improving blood flow thr….
ucl.ac.uk
Weight loss surgery may reduce the risk of developing heart failure for people living with obesity by improving blood flow through their heart muscle, according to a new study led by UCL researchers.
0
4
0
RT @ChengshengJ: Our new study shows a reduced use of pharmacological treatment for heart failure after a cancer d….
onlinelibrary.wiley.com
Aims We aim to evaluate change in the use of prognostic guideline-directed medical therapies (GDMTs) for heart failure (HF) before and after a cancer diagnosis as well as the matched non-cancer...
0
4
0
Standing room only for controversial discussion around AI in echo at #ASE2024. 100% of audience see value but 0% want unsupervised evaluation (we need the human in the loop).
0
4
19
Don’t ignore general cardiac disease in #cardioonc. Fantastic presentation from @AnaBaracCardio at #ASE20214
2
0
17